Overview

Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of the FLUID Trial is to conduct a pragmatic, multi-centre, open label randomized cluster cross-over trial (RCT) to determine whether fluid administration with 0.9% saline as compared to Ringer's lactate decreases death or re-admission to hospital with 90 days of the index admission.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ottawa Hospital Research Institute
Criteria
Inclusion Criteria:

● All adult and pediatric patients with an index admission to the participating hospitals
during study periods

Exclusion Criteria:

- neonates

- physicians may opt out of the use of the allocated study fluid for a specific patient